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BACKGROUND: We previously reported Brucea javanica leaf extract (BJLE) induced apoptosis in human oral squamous cell carcinoma (HSC2) cells 
by attenuation of mitochondrial membrane permeability. 
However, further underlying mechanism is not known yet. 
Therefore, we conducted a study to investigate activation of 
Caspases related to attenuation of mitochondrial membrane 
permeability in BJLE-treated human oral squamous cell 
carcinoma.
METHODS: B. javanica leaves were collected, identified, 
minced, dried, extracted with distilled ethanol at room 
temperature for 24 hours, filtered and evaporated. Resulted 
BJLE was stored at 4°C. HSC-2 and HSC-3 cells were fasted 
for 12 hours and treated with BJLE in various concentrations 
for 24 hours. Treated HSC-2 and HSC-3 cells were lysed 
and subjected to western blot, to detect cleaved-Caspase-9, 
cleaved-Caspase-3 and β-actin. All visualized bands were 
captured and quantified.
Abstract RESULTS: Low numbers and morphological alterations of adherent HSC-2 and HSC-3 cells were observed in the 
group of cells treated with 500, 100 and 10 μg/mL BJLE. 
Numbers of adherent HSC-2 and HSC-3 cells treated with 
BJLE were shown decreased along with the increase of 
BJLE concentrations. Meanwhile, numbers of floating 
HSC-2 and HSC-3 cells were increased. Bands of cleaved-
Caspase-9 and cleaved-Caspase-3 were observed in HSC-
2 and HSC-3 cells treated with 500 and 100 μg/mL BJLE. 
Higher-density bands of cleaved-Caspase-9 and cleaved-
Caspase-3 were observed in HSC-2 and HSC-3 cells treated 
with 500 μg/mL BJLE than 100 μg/mL BJLE.
CONCLUSION: BJLE could induce apoptosis by 
activation of Caspase 9 and Caspase 3 of mitochondrial 
apoptotic pathway in human oral squamous cell carcinoma.
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Many anticancer drugs are obtained from natural sources. 
Among them, reports in herbs have shown various potential 
for medicine.(1,2) The herbal medicine Brucea javanica 
(B. javanica) has demonstrated a variety of anti-cancer, 
anti-malarial, and anti-inflammatory properties. As an 
anti-cancer, B. javanica has been investigated in lung (3), 
gastrointestinal (3), cervical (4), non-small cell lung (5), 
hepatocellular (5), breast (5), oesophageal (5), pancreatic 
(6-8) and bladder (9) cancers. The anti-cancer property of 
B. javanica is specific, since there are significant differences 
in cytotoxicity between cervical cancer cells (CaSki, C33A, 
and HeLa) and normal keratinocyte (PHKs).(4)
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 B. javanica extract induces cancer apoptosis. 
Apoptosis proceeds through a mitochondrial dependent 
pathway associated with Caspase 3 activation in MDA-
MB231 breast cancer cells.(5) Weak activation of Caspase 8 
was observed upon B. javanica extract treatment in MDA-
MB231 cells.(5) On the other hand, Caspase 3 activity was 
highly activated in B. javanica extract-treated MDA-MB231 
cells compared to untreated controls.(5) Study in T24 
bladder cancer cells has shown that B. javanica significantly 
induced the expressions of Caspase-3 and Caspase-9 in T24 
cells, whereas the expressions of nuclear factor (NF)-κB 
and cyclooxygenase (COX)-2 proteins were inhibited.(9) In 
addition the p53-dependent and p53-independent activities 
contribute to B. javanica extract-induced apoptosis.(4) 
Under treatment of B. javanica extract, p53 level of cervical 
cancer HeLa cells was increased and associated with 
apoptosis.(4)
 We previously reported B. javanica leaf extract (BJLE) 
induced apoptosis in human oral squamous cell carcinoma 
(HSC2) cells by attenuation of mitochondrial membrane 
permeability.(10) However, further underlying mechanism 
is not known yet. Therefore, we conducted a study to 
investigate activation of Caspases related to attenuation 
of mitochondrial membrane permeability in BJLE-treated 
human oral squamous cell carcinoma.
Methods
Plant Extraction
BJLE was isolated as described by Wicaksono, et al.(10). 
Briefly, collected leaves were identified, minced, dried and 
extracted with distilled ethanol at room temperature for 24 
hours. Further the solution as filtered and evaporated using 
rotatory evaporator. Resulted BJLE was stored at 4°C. 
Cell Culture and BJLE Treatment
Human oral squamous cell carcinoma (HSC)-2 and HSC-3 
cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) with high glucose (Sigma Aldrich, St. Louis, MO, 
USA), supplemented with 10% fetal bovine serum (FBS) 
and 1% penicillin-streptomycin. HSC-2 and HSC-3 cells 
were incubated in a humidified incubator with 5% CO2, 
37°C. After HSC-2 and HSC-3 cells were seeded and fasted 
for 12 hours, BJLE was added in various concentrations. 
For a positive control, doxorubicin was added.
Western blot 
Treated HSC-2 and HSC-3 cells were lysed with lysate 
buffer containing 50 mM Hepes/NaOH, 0.5 M NaCl, 5 mM 
EDTA, 20 mM β-mercaptoethanol, 0.2% Triton X-100, 
50 mM sodium fluoride, 30 mM sodium pyrophosphate, 
2 mM sodium orthovanadate and 1 mM p-amidinophenyl 
methanesulfonyl fluoride. Then 15 μg lysates were 
separated by sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) and transferred to a 
polyvinylidene difluoride sheet. After blocking with 5% 
skimmed milk in phosphate buffered saline (PBS), the 
sheets were probed with the following 1:1000 diluted 
antibodies: rabbit polyclonal anti-cleaved-Caspase-9 
(Asp315) (Cell Signaling, Beverly, MA, USA) and 
rabbit polyclonal anti-cleaved-Caspase-3 (Asp175) (Cell 
Signaling) antibodies. The secondary antibody was 1:2000 
diluted horseradish peroxidase (HRP)-conjugated donkey 
anti-rabbit (Amersham, Buckinghamshire, UK) or anti-
mouse (Amersham) IgG antibody. The bound antibodies 
were visualized using Immun Star HRP Chemiluminescent 
Kit (Bio-Rad Laboratories, Inc.). Membrane was then 
stripped with Seppro stripping buffer (Sigma-Aldrich), 
blocked with 5% skim milk in PBS, probed with mouse 
monoclonal anti-β-actin (C-4, Santa Cruz Biotechnology) 
antibodies), bound with anti-mouse IgG secondary antibody 
and visualized with chemiluminescent kit. All visualized 
bands were captured using Alliance 4.7 (UVItech, Ltd., 
Cambridge, UK) and quantified using UVIband software 
(UVItech, Ltd.).
Numbers and Morphological Alteration of BJLE-treated 
Cells
High numbers and normal appearances of adherent HSC-2 
(Figure 1A) and HSC-3 (Figure 2A) cells were shown in the 
untreated group. High numbers and unaffected appearances 
of adherent HSC-2 (Figure 1B) and -3 (Figure 2B) cells 
were also shown in the group of 1% DMSO-treated cells. 
In contrast, low numbers and morphological alterations 
of adherent HSC-2 cells were observed in the group of 
cells treated with 3 μM Doxorubicin (Figure 1C), 500 μg/
mL BJLE (Figure 1D), 100 μg/mL BJLE (Figure 1E) and 
10 μg/mL BJLE (Figure 1F). Similarly, low numbers and 
morphological alterations of adherent HSC-3 cells were 
also observed in the group of cells treated with 3 μM 
Doxorubicin (Figure 2C), 500 μg/mL BJLE (Figure 2D), 
100 μg/mL BJLE (Figure 2E) and 10 μg/mL BJLE (Figure 
2F).
 Numbers of adherent HSC-2 (Figure 1D-E) and 
HSC-3 (Figure 2D-E) cells treated with BJLE were shown 
decreased along with the increase of BJLE concentrations. 
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Figure 1. BJLE reduced number of HSC-2 cells. HSC-2 cells were untreated (A) or treated with 1% DMSO (B), 3 μM Doxorubicin (C), 
500 μg/mL BJLE (D), 100 μg/mL BJLE (E) and 10 μg/mL BJLE (F) for 24 hours. Cells were documented under inverted microscope. Size 
bars were provided as indicated in the picture.
In addition, increasing numbers of floating HSC-2 (Figure 
1D-E) and HSC-3 (Figure 2D-E) cells were observed along 
with the increase of BJLE concentrations as well.
Activation of Caspase-9 and Caspase-3 in BJLE-treated 
Cells
Bands of cleaved-Caspase-9 and cleaved-Caspase-3 were 
observed in HSC-2 (Figure 3A) and HSC-3 (Figure 3B) 
Figure 2. BJLE reduced number of HSC-3 cells. HSC-3 cells were untreated (A) or treated with 1% DMSO (B), 3 μM Doxorubicin (C), 
500 μg/mL BJLE (D), 100 μg/mL BJLE (E) and 10 μg/mL BJLE (F) for 24 hours. Cells were documented under inverted microscope. Size 
bars were provided as indicated in the picture.
cells treated with doxorubicin, 500 μg/mL BJLE and 100 
μg/mL BJLE. Meanwhile, the bands were not observed in 
untreated, 1% DMSO or 10 μg/mL BJLE-treated HSC-2 and 
HSC-3 cells. Higher-density bands of cleaved-Caspase-9 
and cleaved-Caspase-3 were observed in HSC-2 and HSC-3 
cells treated with 500 μg/mL BJLE than 100 μg/mL BJLE. 
Similar β-actin band densities were observed in all samples 
of HSC-2 and HSC-3 cells.
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on BJLE-induced apoptosis mechanism related to 
attenuation of mitochondrial membrane permeability as we 
found earlier in our previous study. Current results show that 
treatment of BJLE decreased numbers of adherent HSC-2 
and HSC-3 cells, and increased floating HSC-2 and HSC-3 
cells. This suggests that BJLE could decrease viable HSC-2 
and HSC-3 cells by induction of apoptosis. This result is 
in accordance to our previous results(10) and other reports.
(4-9) We also found that under treatment of BJLE, Caspase 
9 and Caspase 3 were activated in HSC-2 and HSC-3 cells, 
marked by high density of cleaved-Caspase 9 and cleaved-
Caspase 3. Among all BJLE concentrations tested, we found 
that cleaved-Caspase 9 and cleaved-Caspase 3 were clearly 
seen in HSC-2 and HSC-3 cells treated with 500 μg/ml 
BJLE and 100 μg/ml BJLE. These results are in accordance 
to lower numbers of adherent HSC-2 and HSC-3 cells, and 
Apoptosis has been suggested as a strategy for cancer 
chemotherapy.(11-14) Apoptotic morphological changes 
involve cytoplasmic shrinkage, plasma membrane blebbing, 
chromatin condensation and apoptotic bodies formation.
(12) Double-strand cleavages of DNA occur in apoptotic 
cells.(11-16) Natural products have played a major role in 
apoptosis induction of osteosarcoma cells.(17,18) Due to 
the apoptosis induction by these natural products,  several 
apoptosis-related proteins were induced, including Caspase 
3, Caspase 7, Caspase 8 and Caspase 9, B cell lymphoma 
(Bcl)-2 and Survivin, Bcl-2-associated x protein (Bax), p53 
upregulated modulator of apoptosis (Puma) and Fas.(18)
 In our current study, we pursued a further investigation 
Figure 3. BJLE induced activation of Caspase-9 & -3. HSC-2 (A) and -3 (B) cells were treated with 1% DMSO, 3 μM Doxorubicin, 500 
μg/mL BJLE, 100 μg/mL BJLE or 10 μg/mL BJLE as indicated in the panel, for 24 hours. Cells were collected, lysed, further processed for 
western blot analysis as described in Methods. C-Casp9: cleaved-Caspase 9; C-Casp3: cleaved-Caspase 3.
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